Changes in etiology, cause of death, survival, and mortality rates in cardiac transplant patients from 1998 to 2011 [1998-2011 arasi dönemde kalp nakli hastalarinda etyoloji, ölüm nedenleri, sagkalim ve mortalite oranlarindaki degişim]
dc.contributor.author | Güngör H. | |
dc.contributor.author | Nalbantgil S. | |
dc.contributor.author | Oguz E. | |
dc.contributor.author | Ayik M.F. | |
dc.contributor.author | Zoghi M. | |
dc.contributor.author | Ertugay S. | |
dc.contributor.author | Karakula S. | |
dc.contributor.author | Engin Ç. | |
dc.contributor.author | Yagdi T. | |
dc.contributor.author | Özbaran M. | |
dc.date.accessioned | 2019-10-26T21:46:34Z | |
dc.date.available | 2019-10-26T21:46:34Z | |
dc.date.issued | 2012 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Objectives: We retrospectively analyzed changes in heart failure etiology, causes of death, mortality and survival rates in cardiac transplant patients from 1998 to 2011. Study design: A total of 144 patients (112 men, 32 women; mean age 40.2±14.3 years) underwent cardiac transplantation between February 1998 and January 2011. The patients were divided into two groups; hence, 63 patients (group 1; mean age 42.5±12.6 years) receiving transplantation up to January 2006, and 81 patients (group 2; mean age 38.4±15.3 years) receiving transplantation from 2006 to 2011. In the latter period, a ventricular assist device was used in 17 patients before transplantation. Results: Dilated cardiomyopathy was the main cause of heart transplantation in both groups (71.4% vs. 74.1%). Overall mortality, in-hospital mortality (<30 days), and late mortality (?30 days) rates were 39.6% (n=57), 13.9% (n=20), and 25.7% (n=37), respectively. Survival rates for 1, 2, 5, and 10 years were 76%, 69%, 59%, and 46%, respectively. The second group had significantly lower rates of overall mortality and late mortality compared to group 1 (29.6% vs. 52.4%, p=0.005; 16.0% vs. 38.1%, p=0.002, respectively), whereas early mortality rates were similar. Survival rates were also higher in the second group, but these differences did not reach significance (1-year, 76.1% vs. 74.6%; 2-year, 73.0% vs. 65.1%; 5-year, 63.8% vs. 55.6%; log rank 0.33). In both groups, infections (30.3% vs. 33.3%), right ventricular failure (12.1% vs. 29.2%), and sudden cardiac death (15.2% vs. 16.7%) were the leading causes of death. Conclusion: Our data show that overall and late mortality rates show significant decreases in cardiac transplant patients from 1998 to 2011. © 2012 Türk Kardiyoloji Dernegi. | en_US |
dc.identifier.doi | 10.5543/tkda.2012.01796 | en_US |
dc.identifier.endpage | 32 | en_US |
dc.identifier.issn | 1016-5169 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 22395371 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 26 | en_US |
dc.identifier.uri | https://doi.org/10.5543/tkda.2012.01796 | |
dc.identifier.uri | https://hdl.handle.net/11454/18565 | |
dc.identifier.volume | 40 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | tr | en_US |
dc.relation.ispartof | Turk Kardiyoloji Dernegi Arsivi | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Heart failure/surgery | en_US |
dc.subject | Heart transplantation/mortality | en_US |
dc.subject | Heart-assist devices | en_US |
dc.subject | Risk factors | en_US |
dc.title | Changes in etiology, cause of death, survival, and mortality rates in cardiac transplant patients from 1998 to 2011 [1998-2011 arasi dönemde kalp nakli hastalarinda etyoloji, ölüm nedenleri, sagkalim ve mortalite oranlarindaki degişim] | en_US |
dc.type | Article | en_US |